Lee J, Koh J, Kim HK, Hong S, et al. Bevacizumab plus atezolizumab following progression on atezolizumab monotherapy in pretreated non-small cell lung cancer patients: An open-label, two-stage, phase II trial. J Thorac Oncol 2022 Apr 12. pii: S1556-0864(22)00193.
PMID: 35427805